Meluzio Michael Vincent
SEC CIK 2138368 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CUE | Cue Biopharma, Inc. | VP, Prin. Accounting Off | 54.6K | — | $169.3K | 3 | 2026-07-09 | 2026-08-13 |
Most active insiders at CUE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lin Shao-Lee | CEO, Dir | — | $1.61M |
| 2 | Ray Sumita | Chief Legal Compliance Off, Corp. Sec | — | $265.6K |
| 3 | Meluzio Michael Vincent | VP, Prin. Accounting Off | — | $169.3K |
| 4 | Sarraf Pasha | Dir | $99.7K | — |
| 5 | Meehan Viola Mong | Dir | — | — |
| 6 | Borie Dominique Christian | Chief Medical Off, Head of Research, Development | — | — |
| 7 | Garzone Pamela | Dir | — | — |
| 8 | Camardo Daniel A. | Dir | — | — |
| 9 | Ahlers James M | CFO | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-17 18:19 | 2026-08-13 | CUE | Cue Biopharma, Inc. | Meluzio Michael Vincent | VP, Prin. Accounting Off | M - OptEx | $0.00 | +13.6K | 54.6K | +33% | $0 |
| DM | 2026-08-17 18:19 | 2026-08-13 | CUE | Cue Biopharma, Inc. | Meluzio Michael Vincent | VP, Prin. Accounting Off | S - Sale+OE | $30.09 | -5,628 | 49.0K | -10% | -$169.3K |
| D | 2026-07-10 19:34 | 2026-07-09 | CUE | Cue Biopharma, Inc. | Meluzio Michael Vincent | VP, Prin. Accounting Off | A - Grant | $0.00 | +40.9K | 40.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations